Preclinical Studies of Flonoltinib Maleate, a Novel JAK2/FLT3 Inhibitor, in Treatment of JAK2V617F-induced Myeloproliferative Neoplasms (vol 12, 37, 2022)
BLOOD CANCER JOURNAL(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
BLOOD CANCER JOURNAL(2024)